Exogene
Manufacturing · United Kingdom · 1-10 Employees
View Company Info for Free
Overview
Headquarters
Oxford Bioescalator Innovation Building ...Website
www.exogene.co.ukRevenue
<$5 MillionIndustry
About Exogene
Exogene Org Chart
Is Exogene your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Exogene
Product Launch: Get notified when Exogene launches new products
Check out if Exogene is spiking on competitors!
Check if Exogene has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Exogene, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Exogene had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Exogene has new funding data
Earning: See what the market has to say on Exogene recently announced quarterly report
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Exogene
Compare insights from companies similar to Exogene, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Exogene Tech Stack
A closer look at the technologies used by Exogene
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Exogene
Exogene is a techbio startup focused on developing innovative TCR-based therapies for cancer treatment using deep learning technology. Their generative AI platform enables the discovery of high-affinity and non-cross-reactive TCRs, which are essential for eradicating solid tumors. The company aims to harness the natural ability of human T-cells to... Read More